Revvity stock heads into the open after a modest gain
Published on 09/14/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revvity stock closed at USD 123.69 on the NYSE on September 11, 2026, up 0.4 percent from the prior session. Compared with its 52-week range, the close left the shares closer to the middle of their recent trading corridor, underscoring a relatively steady performance against broader health-care peers.
September 11, 2026 in numbers
Revvity Inc. (ISIN US76155R1086, NYSE: RVTY) ended the last completed session on September 11, 2026 with a closing price of USD 123.69 on the NYSE, after trading between an intraday low of USD 122.50 and a high of USD 124.40. Based on NYSE data, the daily gain of 0.4 percent came on a volume of around 750,000 shares, close to the recent average for Revvity. The same day, the S&P 500 index finished nearly unchanged, so the company’s slight advance represented a modest outperformance versus the broad US equity benchmark. Within the diagnostics and life-sciences tools space, several peers showed similarly muted moves, indicating that the session was characterized more by incremental sector positioning than by company-specific news.
Outlook for today
Today, investors in Revvity focus primarily on sector and macro signals rather than a specific company event. Earnings and guidance from larger health-care and laboratory-equipment players, as listed in the US earnings calendar compiled by Yahoo Finance, can influence sentiment toward Revvity because its business depends on research and diagnostic spending trends. Broader market direction today may also be colored by scheduled US economic indicators and any movement in interest-rate expectations, which matter for longer-duration growth stories in the health-care tools segment. Against that backdrop, Revvity enters today’s session with a slightly firmer footing after its modest gain on September 11, 2026.
